Loading search results
TRANSHEMO
Sponsor study identifier
observational
277
1 country
29
Study Start
February 13, 2017
Actual (reported)Primary Completion
February 27, 2019
Actual (reported)Study Completion
February 27, 2019
Actual (reported)Severe haemophilia is a rare disease characterized by spontaneous bleedings from early childhood, which may lead to various complications especially in joints. Due to advances in medical care and more specifically in the development of prophylactic strategies by the application of clotting factor concentrates, life expectancy of persons with severe haemophilia has significantly increased over the last decades. This progress requires a long-term follow-up, including into adulthood. The adherence to a regular clinical follow-up and to a prophylactic treatment then depends on how successful patients' transition from childhood to adulthood has been as this process involves a transfer of responsibility from parents to patients concerning the management of their health. Beyond the issue of patients' adherence, a suboptimal transition may also impair quality of life and the entry into adulthood, especially at the social, emotional and professional levels. Only a few studies have been conducted to identify the specific needs and difficulties young persons with severe haemophilia experience during their transition from childhood to adulthood, and none of these studies has been carried out in France where the features of the health care system are very specific. Therefore, this study aims to address the issue of transition into adulthood among young persons with severe haemophilia in France. This study will focus not only on the facilitators and barriers of the access to health care but also, from a more global perspective, on all the specific concerns and difficulties they may experience as they grow into adulthood which may impair their long-term health related quality of life as well as their personal empowerment. This study will also allow to identify some of the socio- cognitive, emotional, and familial determinants of a good transition into adulthood.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 27, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 4, 2016
Actual (reported)August 15, 2016
Actual (reported)February 13, 2017
Actual (reported)February 27, 2019
Actual (reported)February 27, 2019
Actual (reported)Number of follow-up visits / theoretical number of follow-up visits over the last two years
Adherence to clinical follow-up
Two years
Number of injections of prophylactic treatment realized / theoretical number of injections of prophylactic treatment over the last three months
Adherence to prophylactic treatment
3 months
Patient-reported adherence
one day
Physician-reported adherence of the patient
one day
Number of haemorrhagic events
one day
adolescents (14-17 years old)
young adults (20-29 years old)
quantitative and qualitative data collection will be proposed.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
cohort of persons with severe haemophilia
CHU D'Amiens
Amiens, 80054, France
CHU de Besançon
Besançon, 25020, France
CHU Bordeaux
Bordeaux, 33076, France
Chu Brest
Brest, 29609, France
CHU CAEN
Caen, 14033, France
Ch Chambery
Chambéry, 73011, France
Chu Clermont-Ferrand
Clermont-Ferrand, 63003, France
Resseguier N, Rosso-Delsemme N, Beltran Anzola A, Baumstarck K, Milien V, Ardillon L, Bayart S, Berger C, Bertrand MA, Biron-Andreani C, Borel-Derlon A, Castet S, Chamouni P, Claeyssens Donadel S, De Raucourt E, Desprez D, Falaise C, Frotscher B, Gay V, Goudemand J, Gruel Y, Guillet B, Harroche A, Hassoun A, Huguenin Y, Lambert T, Lebreton A, Lienhart A, Martin M, Meunier S, Monpoux F, Mourey G, Negrier C, Nguyen P, Nyombe P, Oudot C, Pan-Petesch B, Polack B, Rafowicz A, Rauch A, Rivaud D, Schneider P, Spiegel A, Stoven C, Tardy B, Trossaert M, Valentin JB, Vanderbecken S, Volot F, Voyer-Ebrard A, Wibaut B, Leroy T, Sannie T, Chambost H, Auquier P. Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study. BMJ Open. 2018 Jul 25;8(7):e022409. doi: 10.1136/bmjopen-2018-022409.
Urielle DESALBRES
ASSISTANCE Publique Hôpitaux de Marseille
277 participants (actual enrollment reported by the registry).
First Submitted
August 4, 2016
First Posted
August 15, 2016
Study Start
February 13, 2017
Actual (reported)Contact the study team to confirm eligibility.
Chu Dijon
Dijon, 21034, France
CHU Grenoble
Grenoble, 38043, France
CH Versailles/ Le Chesnay
Le Chesnay, 78157, France
Chu Lille
Lille, 59037, France
CHU Limoges
Limoges, 87000, France
Hospices Civiles de Lyon
Lyon, 69677, France
Assistance Publique Hôpitaux de Marseille Hôpital de la Timone
Marseille, 13354, France
CH Montmorency
Montmorency, 95160, France
CHU Montpellier
Montpellier, 34295, France
CHU Nancy
Nancy, 54511, France
CHU Nantes
Nantes, 44093, France
CHU Nice
Nice, 06202, France
Assistance Publique Hôpitaux de Paris
Paris, 75015, France
Assistance Publique Hôpitaux de Paris
Paris, 94275, France
CHU Reims
Reims, 51092, France
CHU Rennes
Rennes, 35000, France
Chu Rouen
Rouen, 76031, France
CHU Réunion
Saint-Denis, 97405, France
CHU Saint-Etienne
Saint-Etienne, 42055, France
CHU Strasbourg
Strasbourg, 67200, France
CHU Toulouse
Toulouse, 31059, France
CHU Tours
Tours, 37170, France
Primary Completion
February 27, 2019
Actual (reported)Study Completion
February 27, 2019
Actual (reported)Last Updated
February 14, 2023
Record last verified: 2023-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: